GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » COGS-to-Revenue

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) COGS-to-Revenue : 0.63 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings COGS-to-Revenue?

Integrated Diagnostics Holdings's Cost of Goods Sold for the three months ended in Mar. 2024 was $16.45 Mil. Its Revenue for the three months ended in Mar. 2024 was $25.94 Mil.

Integrated Diagnostics Holdings's COGS to Revenue for the three months ended in Mar. 2024 was 0.63.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Integrated Diagnostics Holdings's Gross Margin % for the three months ended in Mar. 2024 was 36.59%.

Integrated Diagnostics Holdings COGS-to-Revenue Historical Data

The historical data trend for Integrated Diagnostics Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings COGS-to-Revenue Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.49 0.46 0.59 0.63

Integrated Diagnostics Holdings Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.65 0.65 - 0.63

Integrated Diagnostics Holdings COGS-to-Revenue Calculation

Integrated Diagnostics Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=84.053 / 133.367
=0.63

Integrated Diagnostics Holdings's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=16.451 / 25.942
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings  (OTCPK:IDGXF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Integrated Diagnostics Holdings's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 16.451 / 25.942
=36.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Integrated Diagnostics Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » COGS-to-Revenue
Comparable Companies
LSE:DXRX LSE:AGL LSE:LLAI LSE:PRM LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Website
https://www.idhcorp.com
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021